Channel
@dongasocio
On this record: Growth · Engagement · Reactions · Posts · Cite this entry
635subscribers
-10 since we began measuring on 7 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
| Telegram ID | -1002169985144 |
|---|---|
| Type | Channel |
| Username | @dongasocio |
| Created | Between 1 June 2024 and 30 September 2024— estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 8 August 2026 |
| Last confirmed live | 29 August 2026 |
| Measurements held | 5 |
| Confirmed unchanged | 1 time, most recently 29 August 2026 |
| On Telegram | t.me/dongasocio |
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 29 Aug 2026, 00:13 | 635 | -7 |
| 21 Aug 2026, 02:19 | 642 | -2 |
| 15 Aug 2026, 02:08 | 644 | -1 |
| 8 Aug 2026, 02:47 | 645 | no change |
| 7 Aug 2026, 18:21 | 645 | first reading |
20 posts held, back to 15 July 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 pageof Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 30 July 2026. An engagement rate over an empty window would be a number about nothing.
50 reactions across 19 posts, in 8 distinct kinds. The most used accounts for 40.0% of them.
| Reaction | Count | Share | Share, drawn |
|---|---|---|---|
| ❤ | 20 | 40.0% | |
| 👍 | 12 | 24.0% | |
| 👏 | 8 | 16.0% | |
| 👎 | 3 | 6.00% | |
| 🔥 | 3 | 6.00% | |
| 🙏 | 2 | 4.00% | |
| 😭 | 1 | 2.00% | |
| 🥰 | 1 | 2.00% |
No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.
Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.
Coverage. Reactions were read on 19 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 50reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.
Measured over the 20 most recent posts we hold, published 15 July 2026 to 30 July 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.
동아쏘시오그룹 뉴스📰 2026.07.31(금) 저,,,다음주 휴가입니다 다녀와서 뵈어요🫡 ‘1963년 그대로’…동아제약 박카스, 출시 63주년 기념 ‘레트로 에디션’ 한정 판매 https://biz.heraldcorp.com/article/10825170?ref=naver 빨리 당장 구입해야겠다요👍 부작용없는 비만약 나오나…임상서 중도탈락 0명 https://www.newsis.com/view/NISX20260729_0003728584 비만약의 새로운 가능성을 보여줘야죠🔬 ‘RNA 신약’ 대중화에…K바이오도 참전 https://www.sedaily.com/article/20073925?ref=naver RNA 시장 확장은 큰 기회가 되겠죠🌟 제약 잇단 참전…더마코스메틱 시장, 성분 넘어 '제품력' 승부 https://www.dailyp…
❤1😭1🙏1
동아쏘시오그룹 뉴스📰 2026.07.30(목) 동아제약, 10년간 실적 2배↑…박카스·일반약 성장이 주효 https://www.dailypharm.com/user/news/340916?REFERER=NP 박카스가 받치고 일반약이 끌고 좋아써~🏇 동아참메드, 차세대 연성내시경 국내 출시…국산화 첫 걸음 https://dealsite.co.kr/articles/166154 국산 고퀄리티 연성내시경 시대 개막🎊 에스티팜, 올리고·저분자 투트랙 수주 3억 달러 돌파…체질 개선 속도 https://www.ngetnews.com/news/articleView.html?idxno=551930 시장이 커지니까 에스티팜 실적도 더 좋아지겠죠👍 '매출 불패' 박카스…상반기 1480억 달성 신기록 https://www.newsis.com/view/NISX…
동아쏘시오그룹 뉴스📰 2026.07.29(수) OTC·물류 '현금창출'에 CDMO '성장성'…'동아쏘시오'의 달라진 체질 https://www.kpanews.co.kr/news/articleView.html?idxno=539335 모든 사업 분야에서 고르게 성장하는게 중요하겠죠🙂↕️ 에스티팜, 상업화 품목 확대에 성장세 지속…하반기 수익성 개선 기대 https://www.yakup.com/news/index.html?mode=view&cat=12&nid=330374 하반기에 더 좋아지는거 아시져🤣 11억 달러에 팔린 ‘클라우딘18.2 ADC’ 3상 OS 입증 성공…K바이오도 들썩 https://www.yakup.com/news/index.html?mode=view&cat=12&nid=330368 앱티스가 일찌감치 겨냥해서 준비중이었죠👍…
❤1
동아쏘시오그룹 뉴스📰 2026.07.28(화) 동아쏘시오홀딩스, 2분기 역대 최대 실적…매출 첫 4000억 돌파 https://www.news1.kr/bio/pharmaceutical-bio/6240295 폭풍성장 계속 가즈아🚀 동아에스티, 2분기 매출 2천78억원…역대 최대 https://www.yna.co.kr/view/AKR20260727120700017?input=1195m 열심히 성장중인 동아에스티👍 에스티팜, 2Q 영업익 42%↑…"올리고·저분자 상업화" https://www.asiae.co.kr/article/2026072715273983058 상업화 품목과 신규 프로젝트의 콜라보🔥 에스티팜, 코로나 백신 '뚜껑' 시장에 깃발 꽂는다 https://www.dailian.co.kr/news/view/1671283/%EC%97…
👎2❤1👍1
동아쏘시오그룹 뉴스📰 2026.07.27(월) 동아에스티·메타비아, '바노글리펠'로 MASH 치료제 시장 도전 https://biz.chosun.com/science-chosun/bio/2026/07/27/ENFY6J4VD5GLVHKDIW5KXJSO6E/?utm_source=naver&utm_medium=original&utm_campaign=biz MASH는 앞으로 단독부터 병용까지 다양한 가능성을 탐색하는 구간이 되겠져🔬 제약사가 만든 두유·젤리?…건기식 넘어 일반식품으로 확대 https://www.kmib.co.kr/article/view.asp?arcid=0030164450&code=61141611&cp=nv 유행을 만들어버리는 동아제약이라니🤣 동아쏘시오, 13년 전 떼어낸 '제약' 왜 다시 https://news.bizwatch…
🥰1
Photo, posted without a caption
👍1🔥1
📌 담당자 맘대로 뽑아본 리포트 핵심만 콕! 콕! 콕! - 동아제약 흡수합병으로 사업지주로 전환 결정 - 그룹 지원을 통해 글로벌 시장 확장 기대🌍 - 지주회사에서 제약기업으로 전환, 밸류에이션 재평가🌟 투자의견 : BUY TP : 145,000원
👍2❤1
File, posted without a caption
👍1
동아쏘시오그룹입니다💮 DB증권에서 나온 [동아쏘시오홀딩스] 리포트입니다 이명선 연구원님 감사합니다♥️
❤3🔥1
동아쏘시오그룹 뉴스📰 2026.07.24(금) 다시 뛰는 동아제약🔥🔥 동아쏘시오홀딩스, 동아제약 흡수합병…사명은 '동아제약' 유지 방침 https://www.mt.co.kr/thebio/2026/07/23/2026072317562710014 동아쏘시오홀딩스와 동아제약 이제 다시 달립니다🐦🔥 동아쏘시오, 동아제약 현금흐름 품고 '글로벌 도약' 조준 https://www.medipana.com/news/articleView.html?idxno=414944 사업지주사로 전환하면 의사결정이 더 빨라지겠죠📜 국민 브랜드 '동아제약' 남는다…합병 후 새 출발 유력 https://www.kpanews.co.kr/news/articleView.html?idxno=539155 우리에게 더 친숙한 동아제약의 더 큰 도약을 기대해주세요🚀 동아쏘시오홀딩스…
🔥1
동아쏘시오그룹 뉴스📰 2026.07.23(목) 장마에도 지치지 말자구요🌧 세계로 향하는 K제약·바이오…신약·수출·생산 '3박자 성장' https://biz.chosun.com/science-chosun/bio/2026/07/23/6KXH6KHKRZHCJGHT73FSSVOQJI/?utm_source=naver&utm_medium=original&utm_campaign=biz 신약도 수출도 다 꽉 잡아야져✈️ 에스티팜, 올해 계약 2000억 넘어...올리고·저분자신약 ‘투트랙 전략’ https://www.intn.co.kr/news/articleView.html?idxno=2052106 둘다 잘하는 진짜 실력자👍 QR·색상·점자 품은 의약품 패키지, 투약 안전·비용 절감 ‘일석이조’ http://www.doctorstimes.com/news…
❤1👎1
동아쏘시오그룹 뉴스📰 2026.07.22(수) 동아제약, 방송광고페스티벌 시청자투표상 https://www.news1.kr/photos/8018813 광고 맛집 동아제약이 수상했습니다🥇 올해 뜨거웠던 광고 다 모였다...'2026 MTN 방송광고 페스티벌' 성료 https://news.mtn.co.kr/news-detail/2026072116275894693 뜨거웠던 현장에서 빛났던 동아제약📺 동아제약, '듀오버스터 맥스프레시 치약' 출시…구취·충치 케어 https://www.news1.kr/bio/pharmaceutical-bio/6234370 듀오버스터 아시져? 이제 치약으로도 등장🌟 동아참메드, 경성·연성 통합 내시경 시스템 'V1 Smart PRO' 출시 https://www.medipana.com/news/articleView…
❤1
Showing the 12 most recent of 20 posts we hold for @dongasocio. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 29 August 2026 — this entry's latest reading, not the date you are reading this.
“동아쏘시오그룹 PR/IR 공식 채널🐦🔥” (@dongasocio), 635 subscribers as measured 29 August 2026. Telegram Register, tgregister.com/channel/dongasocio.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.